The comprehensive assessment of local immune status of ovarian cancer by the clustering of multiple immune factors (original) (raw)

Analysis of 300 Clinical Cases of Ovarian Cancer

Sakarie Mustafe Hidig

International Journal of Research Publication and Reviews, 2024

View PDFchevron_right

Immune gene expression and response to chemotherapy in advanced breast cancer

Jonas Bergh

British Journal of Cancer, 2018

View PDFchevron_right

Development and Preliminary Evaluation of a Multivariate Index Assay for Ovarian Cancer

Suraj Amonkar

PLoS ONE, 2009

View PDFchevron_right

Classification using hierarchical clustering of tumor-infiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expression

Ikuo Konishi

Modern Pathology, 2008

View PDFchevron_right

Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer

Kevin Elias

Research Square (Research Square), 2021

View PDFchevron_right

Immune system: a double-edged sword in cancer

Lakshmi Narendra

Inflammation Research, 2013

View PDFchevron_right

Specialized Pathology Review in Patients With Ovarian Cancer

Dietmar Schmidt

International Journal of Gynecological Cancer, 2013

View PDFchevron_right

Characterization of ovarian cancer cell lines as in vivo models for preclinical studies

Kristen Bunch

Gynecologic Oncology, 2016

View PDFchevron_right

New horizons in breast cancer: the promise of immunotherapy

Ana Vallejo Benítez

Clinical and Translational Oncology, 2018

View PDFchevron_right

Cancer Immunotherapy: A Systemic Review

Ashesh Chowdhury

Archives of oncology and cancer therapy, 2024

View PDFchevron_right

Dysregulation of Peripheral Blood Mononuclear Cells and Immune-Related Proteins during the Early Post-Operative Immune Response in Ovarian Cancer Patients

Daiva Urbonienė

Cancers, 2023

View PDFchevron_right

Evaluation of immune status in patients with breast cancer in Sokoto, Northwestern, Nigeria

M. Yeldu

International Journal of Research in Medical Sciences, 2016

View PDFchevron_right

Dissecting Tumor-Immune Microenvironment in Breast Cancer at a Spatial and Multiplex Resolution

Jonas Bergh

Cancers, 2022

View PDFchevron_right

Analysis of Gene Expression in Early-Stage Ovarian Cancer

Giovanna Chiorino

Clinical Cancer Research, 2008

View PDFchevron_right

Analysis of tumor populations and immune system interaction model

NORMAH BTE MAAN FS

AIP Conference Proceedings, 2016

View PDFchevron_right

Cancer Immunomics: From Serological Proteome Analysis to Multiple Affinity Protein Profiling

loïk SYLVIUS

Annals of the New York Academy of Sciences, 2007

View PDFchevron_right

Tumor-associated antigens identified by mRNA expression profiling induce protective anti-tumor immunity

Morten Ruhwald

European Journal of Immunology, 2001

View PDFchevron_right

Data from Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells

Tsukasa Baba

2023

View PDFchevron_right

The importance of individual biology in the clinical use of serum biomarkers for ovarian cancer

Simona Ferraro

Clinical Chemistry and Laboratory Medicine (CCLM), 2014

View PDFchevron_right

Treatment and prognosis of epithelial ovarian cancer

ahmad reza arab ameri

2008

View PDFchevron_right

CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells

Suki Kang

Oncogene, 2010

View PDFchevron_right

Immunohistological correlation in different stages of squamous cell carcinoma

Claudiu Margaritescu

Romanian Journal of Morphology and Embryology, 2008

View PDFchevron_right

Early detection of ovarian cancer using group biomarkers

Amy P N Skubitz, Alain Tchagang

Molecular Cancer Therapeutics, 2008

View PDFchevron_right

Assessment of pathogenic variation in gynecologic cancer genes in a national cohort

Luca Lovrečić

Scientific Reports, 2023

View PDFchevron_right

Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells

Tsukasa Baba

Clinical Cancer Research, 2017

View PDFchevron_right

Quantitation of immunocompetence in Hodgkin's disease

guy faguet

Journal of Clinical Investigation, 1975

View PDFchevron_right

Selected Immunohistochemical Prognostic Factors in Endometrial Cancer

Martin Procházka

International Journal of Gynecological Cancer, 2010

View PDFchevron_right

Immunohistochemical Profile of Ovarian Germ Cell Tumours

Roshny Jacob

Journal of Evolution of Medical and Dental Sciences, 2017

View PDFchevron_right

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer

Kimberly Holloway

Cell, 2016

View PDFchevron_right

Vesicular-Bound HLA-G as a Predictive Marker for Disease Progression in Epithelial Ovarian Cancer

Vera Rebmann

Cancers, 2019

View PDFchevron_right

Early detection of ovarian cancer

David Buritica

CA: A Cancer Journal for Clinicians, 1995

View PDFchevron_right

Proliferation Markers for the Differential Diagnosis of Tumor and Inflammation

A. Waarde, van

Current Pharmaceutical Design, 2008

View PDFchevron_right

Racial disparities and the effect of time on ovarian cancer survival among cases identified through the National Cancer Database

Kent Hoskins

Gynecologic Oncology, 2015

View PDFchevron_right

Impact of the Area of Residence of Ovarian Cancer Patients on Overall Survival

Anne-sophie Hamy

Cancers, 2022

View PDFchevron_right

Data from Relapse-Free Survival in Breast Cancer Patients Is Associated with a Gene Expression Signature Characteristic for Inflammatory Breast Cancer

Luc Dirix

2023

View PDFchevron_right